Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Skin cells produce and activate vitamin D, which regulates skin functions and supports hair growth.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Skin health and diseases are closely linked to metabolic processes.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Finasteride causes temporary cell death in BPH tissues.

Metabolic syndrome reduces effectiveness of hair loss treatment.